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The retroviral nucleocapsid (NC) protein contains highly conserved amino acid sequences (-Cys-X2-Cys-X4-His-X4-Cys-)
designated retroviral (CCHC) Zn21 fingers. The NC protein of murine leukemia viruses contains one NC Zn21 finger and
mutants that were competent in metal binding (CCCC and CCHH) packaged wild-type levels of full-length viral RNA but were
not infectious. These studies were extended to human immunodeficiency virus type 1 (HIV-1), a virus with two NC Zn21
fingers. Viruses with combinations of CCHC, CCCC, and CCHH Zn21 fingers in each position of HIV-1 NC were characterized.
Mutant particles contained the normal complement of processed viral proteins. Four mutants packaged roughly wild-type
levels of genomic RNA, whereas the remaining mutants packaged reduced levels. Virions with mutated C-terminal position
NC fingers were replication competent. One interesting mutant, containing a CCCC Zn21 finger in the N-terminal position of
NC, packaged wild-type levels of viral RNA and showed ;5% wild-type levels of infectivity when examined in CD4-expressing
HeLa cells containing an HIV-1 LTR/b-galactosidase construct. However, this particular mutant was replication defective in
H9 cells; all other mutants were replication defective over the 8-week course of the assay. Two long terminal repeat viral DNA
species could be detected in the CCCC mutant but not in any of the other replication-defective mutants. These studies show
that the N-terminal Zn21 finger position is more sensitive to alterations than the C-terminal position with respect to
replication. Additionally, the retroviral (CCHC) NC Zn21 finger is required for early infection processes. The evolutionary
pressure to maintain CCHC NC Zn21 fingers depends mainly on its function in infection processes, in addition to its function
in genome packaging.
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rINTRODUCTION
The retroviral nucleocapsid (NC; Leis et al., 1988) pro-
ein Zn21 finger (-Cys-X2-Cys-X4-His-X4-Cys-; CCHC)
unctions as a domain of the Gag precursor. This Zn21
inger is also an element of the NC protein in the mature
irion after the viral protease has cleaved the NC domain
rom the Gag precursor. Conversion of ligand binding
esidues (Cys or His) to non-ligand-binding residues
isrupts Zn21 coordination, resulting in the loss of the
igid three-dimensional structure (Bess et al., 1992; Sum-
ers et al., 1992). As a domain of the Gag precursor,
unctional Zn21 fingers are necessary for efficient pack-
ging of the viral RNA genome during assembly pro-
esses. Mutation of the ligand binding Cys or His resi-
ues to noncoordinating amino acids results in the dim-
nution of packaged viral RNA (Aldovini and Young, 1990;
orfman et al., 1993; Dupraz et al., 1990; Gorelick et al.,
988, 1990; Me´ric et al., 1988). In HIV-1, mutations that
bolish Zn21 binding result in an 80–95% reduction in
1 To whom reprint requests should be addressed. Fax: (301) 846-
C119. E-mail: gorelick@avpaxp1.ncifcrf.gov.
042-6822/99 92evels of packaged RNA genome compared with wild-
ype virus.
It is apparent that the highly conserved Zn21 finger
otif found in the NC domain of all retroviruses is in-
olved in critical functions at more than one point in the
irus life cycle. Previous publications provided indirect
vidence that the retroviral NC Zn21 finger is critical for
nfection processes after assembly. There has been the
onsistent observation that mutations of the Zn21 coor-
inating residues result in a greater defect in infectivity
han in genomic RNA packaging (Dorfman et al., 1993;
orelick et al., 1996, 1988, 1990; Me´ric et al., 1988; Me´ric
nd Goff, 1989; Me´ric and Spahr, 1986). Thus mutations
ffecting the ligand binding residues also affect other
teps in the viral infection process.
In a previous study, it was found that the CCHC NC
n21 finger is essential for infection processes. The
oloney murine leukemia virus (Mo-MuLV) system was
sed because MuLV has only one Zn21 finger in its NC
rotein, and this simplified analysis of the mutants. Mo-
uLV mutants were constructed in which ligand binding
esidues were maintained in the NC Zn21 finger (i.e.,
CCC and CCHH). Mutant virions recognized and pack-
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93HIV-1 NC Zn21 FINGER MUTANTSged viral RNA genomes at wild-type levels. Surprisingly,
hese mutants were defective in infectivity (Gorelick et
l., 1996). This result demonstrated the direct involve-
ent of the retroviral CCHC NC Zn21 finger in infection
rocesses, in addition to its function in genome packag-
ng determined in other studies.
To extend these studies to human immunodeficiency
irus type 1 (HIV-1), a virus with two NC Zn21 fingers,
ets of mutations were introduced into the gene coding
or HIV-1 NC. These mutants are composed of combina-
ions of CCCC, CCHH, and CCHC Zn21 fingers in the N-
nd C-terminal positions of NC, yielding eight mutants
Table 1). The characteristics of all eight mutants are
resented and compared with those of wild-type HIV-1.
lthough two mutants (CCHC/CCCC and CCHC/CCHH)
ould replicate in long term culture, they were less in-
ectious than wild-type virus when tested in a number of
ermissive cell lines. The remaining mutants were rep-
ication defective. A number of mutants had the pheno-
ype that was observed in the Mo-MuLV CCCC and
CHH mutants (i.e., mutants competent in genome pack-
ging but replication defective; Gorelick et al., 1996).
utants described in this manuscript will provide essen-
ial tools for determining the role or roles of the NC Zn21
ingers in early infection events.
RESULTS
In the past, a number of HIV-1 retroviral NC Zn21 finger
utants have focused on disrupting Zn21 binding to
etermine the function of the Zn21 finger in the viral life
ycle. In this study we wanted to address how mutations
T
NC Protein Zn21 Finger Mutatio
Mutation(s)a
Zn21 finger positionb
N-Terminal C-Termina
2)-Controle
one-wild typef CCHC CCHC
is-233Cys/His-443Cys CCCC CCCC
is-233Cys/Cys-493His CCCC CCHH
ys-283His/His-443Cys CCHH CCCC
ys-283His/Cys-493His CCHH CCHH
is-233Cys CCCC CCHC
ys-283His CCHH CCHC
is-443Cys CCHC CCCC
ys-493His CCHC CCHH
a Number refers to amino acid position in the mature HIV-1 NC prot
b Zn21 finger position refers to the N-terminal (first) or C-terminal (se
CHC refer to ligand-binding residues in the finger.
c Determined by p24CA antigen ELISA.
d cpm of [3H]TTP incorporated/ml of culture fluid.
e 293T cells transfected with sheared salmon sperm carrier DNA alon
f 293T cells transfected with the wild-type HIV-1 clone, pNL4-3.n HIV-1 NC Zn21 fingers, that do not abolish Zn21 bind- ang, affected virion properties. This is similar to the stud-
es presented on Mo-MuLV mutants by workers at this
aboratory (Gorelick et al., 1996) and on an HIV-1 mutant
y Demene et al. (1994) and Tanchou et al. (1998).
rotein composition of mutant and wild-type viral
articles
Eight full-length proviral mutants, based on pNL4–3
lone of HIV-1 (Adachi et al., 1986), were constructed,
eplacing ligand binding residues with other ligand bind-
ng residues (i.e., Cys for His or vice versa). This was
erformed through PCR procedures in which primers
sed to amplify regions of interest contained the perti-
ent mutations. The following alterations, in combination
r alone, were used to create the eight mutants that are
he focus of this work: His-233Cys and His-443Cys
CCCC Zn21 finger in the N- and C-terminal positions,
espectively, of HIV-1 NC) and Cys-283His and Cys-
93His (CCHH Zn21 finger in the N- and C-terminal
ositions, respectively). Table 1 summarizes the various
ombinations of mutations, each containing Zn21 fingers
hat according to in vitro studies, remain in tight associ-
tion with Zn21 (Casas-Finet et al., 1997a, 1997b; Topol et
l., 1998). These full-length clones were transfected into
93T cells, and virus particles were analyzed. Reverse
ranscriptase (RT) activities and p24CA quantities of tran-
iently expressed viruses from a typical transfection are
resented in Table 1. The ratios of pelletable p24CA to
24CA obtained directly from clarified culture superna-
ants (nonpelleted samples) are similar for all mutants
Properties of HIV-1 Particles
Mutant
designation p24CA (ng/ml)c
RT activity 3 106
(cpm/ml)d
0 0
CCHC/CCHC 330 12.2
CCCC/CCCC 85 2.6
CCCC/CCHH 29 2.8
CCHH/CCCC 29 2.7
CCHH/CCHH 50 7.8
CCCC/CCHC 74 6.6
CCHH/CCHC 67 8.4
CCHC/CCCC 238 11.7
CCHC/CCHH 341 13.6
Zn21 finger in the HIV-1 NC protein. Designations CCCC, CCHH, and
ckground of 534 cpm/0.1 ml was subtracted from the RT values shown.ABLE 1
ns and
l
ein.
cond)
e. A band wild-type virus (data not shown), indicating that the
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94 GORELICK ET AL.utant particles are as stable as wild-type particles (i.e.,
articles do not fall apart).
Immunoblot analysis was performed on transiently ex-
ressed virus pelleted from transfected 293T cell super-
atants, and samples were adjusted for similar levels of
FIG. 1. Protein immunoblot analysis of mutant and wild-type virus pa
reated as indicated in Materials and Methods. The same blot was use
sing (A) monoclonal antibody against gp120SU, (B) goat antibody aga
ndicated on the left, and viral proteins of interest are indicated on the24CA. Figure 1A shows viral proteins detected using a Tonoclonal antibody to gp120SU. The processed NC, as
ell as the Gag precursor (Pr55Gag), proteins are de-
ected with the goat p7NC antisera (Fig. 1B). Detection of
24CA is shown in Fig. 1C. Note the increased level of
rocessing of the Gag precursor in the wild-type lane.
. Samples, adjusted for similar levels of p24CA, were fractionated and
each of the three detector antibodies indicated. Immunoblot analysis
C, and (C) goat antibody against p24CA. Sizes of marker proteins arerticles
d with
inst p7Nypically, there are similar levels of gp120SU, p7NC, and
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95HIV-1 NC Zn21 FINGER MUTANTS24CA proteins associated with the mutant and wild-type
iruses.
Full-length mutant and wild-type proviral clones were
lso transfected into HCLZ cells. These cells are similar
o the HeLa CD4-LTR/b-galactosidase cells that are
sed in the MAGI assay described previously (Kimpton
nd Emerman, 1992). Table 2 shows that the transfected
roviral DNA containing these mutations were compe-
ent in their ability to induce b-galactosidase; thus they
re apparently able to synthesize tat mRNA. There also
as significant syncytium formation in the HCLZ cells
ransfected with the mutant viral clones; this indicates
hat Env proteins are being expressed and are compe-
ent for the induction of cell fusion.
iral RNA analysis of mutant and wild-type particles
The p24CA levels were measured in samples contain-
ng transiently expressed mutant and wild-type viruses.
iral RNA was isolated from virions after proteinase K
igestion (Fu et al., 1994; Fu and Rein, 1993; Stewart et
TABLE 2
Analysis of Proviral Clones Transfected and Mutant and Wild-Type
Viruses Used to Infect HCLZ Cells
Virus
Transfected
proviral clones Infectivity analysis
Foci/25-cm2 flask
(3105)a
Foci/ng
of p24CAb S.E.M.
2)-Controlc 0.0 0.0 0.0
CHC/CCHCd 1.1 11,000 170
CCC/CCCC 2.2 0.1 0.1
CCC/CCHH 2.1 0.3 0.1
CHH/CCCC 1.2 0.7 0.2
CHH/CCHH 2.4 0.1 0.0
CCC/CCHC 2.3 330 67
CHH/CCHC 2.3 3.6 0.9
CHC/CCCC 1.9 4900 380
CHC/CCHH 3.3 5400 270
ND116N N.T.
e 3600 890
a Focus values were determined by counting the number of b-galac-
osidase-positive cells per field with 103 eyepieces and objective and
xtrapolating the average number of foci from 20 fields (1 field 5 2.59
m2) to the total area of the flask (25 cm2).
b Focus values were determined by counting the total number of
-galactosidase-positive cells in a 6-well plate and adjusting for dilu-
ion. Monolayers were infected with 1 ml of virus-containing superna-
ant or dilutions thereof. p24CA levels were determined by antigen
LISA. Values presented are an average of the values from two con-
ecutive 24-h harvests from each of two separate transfection/infection
xperiments.
c HCLZ cells transfected with sheared salmon sperm DNA or in-
ected with supernatants from 293T cells transfected with sheared
almon sperm DNA.
d Cells transfected or infected with the wild-type HIV-1 (pNL4-3).
e NT indicates not tested.l., 1990), and contaminating DNA was removed by treat-ent with DNase. RNA levels were then determined by
eal-time RT-polymerase chain reaction (RT-PCR), with
irus RNA levels compared with levels of known quanti-
ies of HIV-1 gag RNA as described essentially by Sury-
narayana et al. (1998). Real-time RT-PCR in the absence
f the reverse transcription step showed that contami-
ating DNA was not present. When normalized for p24CA,
he CCCC/CCCC, CCHH/CCCC, CCHH/CCHH, and
CHH/CCHC mutants were found to package reduced
evels (,50% wild-type levels) of viral RNA compared
ith wild-type virus (Table 3). All others packaged
oughly wild-type levels of viral RNA. The results from
his real-time RT-PCR analysis are in agreement with
orthern blot analyses (data not shown). Northern blot
nalysis examines intact, full-length viral RNA genomes,
hereas the real-time RT-PCR method samples total viral
NA (full-length as well as degraded RNA), containing
he target gag sequence (Suryanarayana et al., 1998) in
he virions. It should be noted that in a previous study by
his laboratory on NC-mutant and wild-type SIV(Mne),
esults from Northern blot analysis were also in com-
lete agreement with the results obtained by RT-PCR
Gorelick et al., 1999).
nfectivity analysis of mutant and wild-type viruses
The infectivity of mutant and wild-type viruses were
ested in both long term culture (with H9 or AA2-clone 5
ells) and short term assays (HCLZ cell infections). Fig-
re 2 shows an analysis of mutant and wild-type HIV-1
upernatants that were cultured for 8 weeks in H9 cells.
ll mutants, except for CCHC/CCCC and CCHC/CCHH,
TABLE 3
Relative RNA Content of Viruses Derived From Transfections with
Wild-Type or NC Mutant HIV-1 (pNL4-3) Proviral Clones
Mutation RNA contenta
(2)-Controlb 0
CCHC/CCHCc 100
CCCC/CCCC 5
CCCC/CCHH 78
CCHH/CCCC 5
CCHH/CCHH 13
CCCC/CCHC 110
CCHH/CCHC 32
CCHC/CCCC 167
CCHC/CCHH 151
a HIV-1 gag RNA content of transfected culture supernatants [copy
quivalent (Eq.)/ml] was determined by real-time RT PCR and then
xpressed as gag RNA copy Eq./ng of p24CA, based on ng/ml p24CA
ontent determined by capture immunoassay for the same specimens
kit from AIDS Vaccine Program, NCI-FCRDC, Frederick, MD). For a
omparison between specimens, the HIV gag RNA copy Eq./ng p24CA
alue for wild-type virus was considered to be 100%.
b (2)-Control indicates samples isolated, prepared, and analyzed
rom 293T cells transfected with sheared salmon sperm DNA.
c CCHC/CCHC indicates wild-type virus.
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96 GORELICK ET AL.acked detectable infectivity in undiluted supernatants,
s shown in Fig. 2A. A common feature of all of the
iruses in Fig. 2A is that none contained a wild-type
CCHC) NC Zn21 finger in the N-terminal position. Con-
ersely, the three viruses that contain wild-type NC Zn21
ingers (CCHC) in the N-terminal position, CCHC/CCCC,
CHC/CCHH, and wild-type (CCHC/CCHC), were infec-
ious to varying degrees, with wild-type being the most
nfectious. End-point dilution analyses of these viruses
re shown in Figs. 2, B–D. Wild-type virus in this analysis
as infectious at a dilution of 1:10,000 but not at a
ilution of 1:100,000. Therefore, the titer of the wild-type
ample (Fig. 2D) was $104 tissue culture infectious dos-
s/ml (TCID/ml). The CCHC/CCCC and CCHC/CCHH mu-
ants (Figs. 2, B and C, respectively) had titers of $101
CID/ml and $102 TCID/ml, respectively. The data pre-
ented in Fig. 2 are reproducible, and similar results
ere obtained when AA2-clone 5 cells were used in-
tead of H9 cells (data not shown).
The two infectious mutants (Figs. 2, B and C) were
FIG. 2. Infectivity analysis of mutant and wild-type HIV-1 viruses in H9
orrected for background (in cpm [3H]TTP incorporated/ml) of starting i
06; CCHH/CCCC, 1.6 3 106; CCHH/CCHH, 5.2 3 106; CCCC/CCHC, 4.8
06; and CCHC/CCHC (wild-type), 8.8 3 106. (A) HIV-1 mutants with firs
ith supernatants from 293T cells transfected with sheared salmon
CHH/CCHH (), CCCC/CCHC (), and CCHH/CCHC (r). (B) CCHC/CC
F), and undilute (E). (C) CCHC/CCHH mutant end-point dilution analys
D) Wild-type HIV-1 end-point dilution analysis. Dilutions are 1:1 million
r).nalyzed to determine whether spread of infection oc-urred with the mutant NC Zn21 finger sequences or as
result of reversion to a wild-type genotype. DNA was
solated from H9 cells taken at various time points from
he infectivity analysis (Fig. 2). The samples indicated in
able 4 were selected to minimize the presence of re-
idual plasmid DNA from the initial transfection by ana-
yzing as diluted a sample as possible that was still
ositive for infection. All samples were subjected to PCR
sing the NL43-NC-sense and NL43-NC-antisense prim-
rs. Samples that were positive for infection contained
ands of the proper size (195 bp), whereas samples
egative for replication (RT activity at background levels)
ere also negative for NC gene PCR products as ex-
ected (Table 4). Samples with a positive PCR signal
ere sequenced. Proviral genomes encoding the CCHC/
CHH mutant NC proteins maintained the CCHC/CCHH
enotype throughout the 8-week culture period. In con-
rast, sequence analysis revealed that the CCHC/CCCC
utant NC protein reverted to a wild-type (CCHC/CCHC)
enotype (Table 4).
utant and wild-type viruses were used to infect H9 cells. RT activities,
m are as follows: SSS, 0; CCCC/CCCC, 2.0 3 106; CCCC/CCHH, 1.7 3
CCHH/CCHC, 8.2 3 106; CCHC/CCCC, 7.7 3 106; CCHC/CCHH, 8.0 3
n NC Zn21 finger alterations. Legend is (2)-Control (H9 cells infected
DNA) (f), CCCC/CCCC (M), CCCC/CCHH (F), CCHH/CCCC (E),
tant end point dilution analysis. Dilutions are 1:1000 (f), 1:100 (M), 1:10
tions are 1:10,000 (f), 1:1000 (M), 1:100 (F), 1:10 (E), and undilute ().
:100,000 (M), 1:10,000 (F), 1:1000 (E), 1:100 (), 1:10 (), and undilutecells. M
noculu
3 106;
t positio
sperm
CC mu
is. Dilu
(f), 1Short-term infectivity analysis using HCLZ cells was
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97HIV-1 NC Zn21 FINGER MUTANTSerformed to determine whether the mutant viruses were
ble to infect and produce spliced messages, ultimately
eading to the production of Tat. Table 2 (columns 2 and
) shows results from the HCLZ cells infected with su-
ernatants containing mutant and wild-type viruses. For
ost of the mutants, results obtained from the H9 infec-
ivity analysis (Fig. 2) correlate with results obtained in
CLZ cells (Table 2). The only exception was the CCCC/
CHC mutant, which was ;5% as infectious as wild-type
irus in the HCLZ assay (Table 2) but was replication
efective in the H9 infectivity assay (Fig. 2A). The HIV-1
ND116N mutant described by Engelman et al. (1995) was
lso tested in this report. It was determined that the
ND116N mutant was ;30% as infectious as wild-type
irus on a per-nanogram of p24CA basis (Table 2). All
ther viruses with mutations in the N-terminal position
C Zn21 finger were highly defective in their ability to
roduce Tat. The three viruses with wild-type sequences
n the first NC Zn21 finger position scored positively in
he HCLZ assay, as expected.
nalysis of viral DNA produced by mutant and wild-
ype viruses on infection of AA2-clone 5 cells
Mutant and wild-type viruses, obtained by transfecting
93T cells with proviral DNA clones, were incubated with
A2-clone 5 cells. After a 24-h incubation period, viral
NA (vDNA) was isolated from the AA2-clone 5 cells as
escribed previously (Hirt, 1967). PCR was performed on
hese DNA preparations using the protocol and primers
escribed by Engelman et al. (1995). PCR analysis of
NA, isolated from cells infected with wild-type HIV-1,
T
Detection of Nucleocapsid Protein Sequences b
Sample/dilutiona
Days post
infection
PCR pro
yield (n
CHH/CCCC/Undiluted 42 N.D
CHC/CCCC/1:10 42 10
CHC/CCCC/1:10 35 25
CHC/CCCC/1:100 42 N.D
CHC/CCHH/1:100 42 13
CHC/CCHH/1:100 35 20
CHC/CCHH/1:1000 42 N.D
CHC/CCHC/1:10,000 42 13
CHC/CCHC/1:10,000 35 30
CHC/CCHC/1:100,000 42 N.D
a Samples are isolated from H9 cells cultured for the infectivity assa
b From each PCR sample, 15 ml was fractionated by agarose gel elec
antisense primers) were compared with band intensities from 1 mg o
c RT activities reported as cpm of [3H]TTP incorporated/0.1 ml of cultu
l are considered negative for infection.
d Genotype of PCR-amplified NC gene regions (determined by nucle
e N.D. indicates that no 195-bp PCR product band was detected.
f N.T. indicates not tested because there was no PCR product to anhows the presence of a 170-bp band indicative of the (wo long terminal repeat (2-LTR) species that results
rom the action of nuclear ligases on full-length linear
DNA species (Lee and Coffin, 1990; Pauza, 1990; Fig. 3).
CR products could be detected in wild-type Hirt super-
atant DNA at a dilution of 1:100 but not at a dilution
f 1:1000. Incubation of AA2-clone 5 cells with the
TD185K/D186L mutant shows no detectable 2-LTR circular
DNA products, as expected. PCR products could be
etected in DNA from cells infected with the CCHC/
CCC and CCHC/CCHH mutant viruses (Fig. 3) at a
ilution similar to that obtained for the wild-type sample.
urprisingly, the noninfectious CCCC/CCHC mutant that
ackages wild-type levels of viral RNA (Table 3) is also
ble to produce easily detectable levels of vDNA in this
CR analysis. 2-LTR circularized vDNA can be detected
t a 1:10 but not a 1:100 dilution for the CCCC/CCHC
utant. For comparison, the IND116N mutant was also
ested; very clear, nonsmeared bands are visible at a
:1000 but not a 1:10,000 dilution in this analysis. All of
he other noninfectious mutants tested were negative for
he presence of the 170-bp PCR product, indicative of
ull-length 2-LTR circular forms of vDNA.
DISCUSSION
In this study, we describe the construction and analy-
is of a series of HIV-1 NC Zn21 finger mutants, some of
hich uncouple the involvement of the fingers in pack-
ging of the genomic RNA from their involvement in early
nfection processes. This study is an extension of our
revious work in which Mo-MuLV NC Zn21 finger mu-
ants were constructed that maintained Zn21 binding
erase Chain Reaction From Infected H9 Cells
RT activity at harvest
(cpm)c Genotype at harvestd
6.0 3 102 N.T.f
1.4 3 105 CCHC/CCHC
5.6 3 105 CCHC/CCHC
4.0 3 102 N.T.
3.9 3 104 CCHC/CCHH
7.5 3 104 CCHC/CCHH
4.5 3 102 N.T.
7.2 3 104 CCHC/CCHC
2.8 3 105 CCHC/CCHC
4.7 3 102 N.T.
n in Fig. 2.
resis. Intensities of the 195-bp PCR bands (using NL43-NC-sense and
-HaeIII digested DNA to determine product yields.
at the time of harvest. Cultures with RT activities of ,2 3 103 cpm/0.1
equencing) at time of harvest (postinfection).ABLE 4
y Polym
duct
g)b
.e
.
.
.
y show
tropho
f fX174
re fluid
otide sCCCC and CCHH) and are distinct from the wild-type
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98 GORELICK ET AL.etroviral NC Zn21 finger motif, CCHC. These Mo-MuLV
utants recognized and packaged wild-type levels of
ull-length genomic RNA, yet they were noninfectious
Gorelick et al., 1996). From these studies of HIV-1, a virus
hat contains two Zn21 fingers in its NC protein, we found
hat a number of the mutants had the phenotype that was
imilar to that of the Mo-MuLV mutants.
All of the HIV-1 mutant proviral clones described in this
ork produced virus particles when transfected into
93T cells (Table 1, Fig. 1). Characterizations indicate
hat Gag, Pol, and Env proteins are produced and appear
o be functional (Fig. 1, Table 1). Viral protease was
unctional because the Gag precursor polyprotein was
rocessed to give mature Gag proteins. However, Gag
recursor processing defects were evident in a number
f the mutants, namely, the mutants with altered Zn21
ingers in the N-terminal position of the NC protein (Fig.
C). This lack of efficient processing has been observed
ith other NC Zn21 finger mutants (Dorfman et al., 1993;
orelick et al., 1990, 1993; Tanchou et al., 1998). Defects
n processing may be due to a number of mechanisms,
ncluding altered folding of the precursor polyproteins,
hich may make some of the viral protease cleavage
ites inaccessible. All mutants transfected into the HCLZ
ells gave a positive b-galactosidase signal in the HCLZ
ell analysis (Table 2, column 1), indicating that Tat
ynthesis occurs after transfection. In addition, signifi-
ant syncytium formation was observed with all clones
fter transfection of the HCLZ cells. This result, along
ith the immunoblot data (Fig. 1A), indicate that Env
roteins are being expressed and are functioning nor-
ally.
FIG. 3. PCR analysis of 2-LTR circularized vDNA species from AA2
upernatant DNA (Hirt, 1967) was isolated from AA2-clone 5 cells infec
93T cells. The RT activities, corrected for background (in cpm 3 108
CCC/CCCC, 2.7; CCCC/CCHH, 6.3; CCHH/CCCC, 4.7; CCHH/CCHH, 8
TD185K/D186L, 0 (roughly equal levels of RTD185K/D186L and wild-type
CHC/CCHC (wild-type), 13.4. PCR was performed using the conditions
he 2-LTR circle form of vDNA. (2)-Control, PCR analysis of cells incuba
NA. The 2% (w/v) agarose gel used to fractionate the PCR products
CR product is shown on the right. fX174-HaeIII digested DNA marker
ndicated at the bottom of the figure.Mutant virions were examined for viral RNA content, Tnd genomes were evident in all of the mutants. With
espect to viral RNA packaging, the CCCC/CCCC, CCHH/
CCC CCHH/CCHH, and CCHH/CCHC mutants were the
ost defective. These mutants contained ,50% wild-
ype levels of genomic RNA as determined by real-time
T-PCR (Table 3). Wild-type levels of genomic RNA were
bserved in the CCCC/CCHH, CCCC/CCHC, CCHC/
CCC, and CCHC/CCHH mutants (Table 3). There is a
iscrepancy in the level of full-length viral RNA observed
n CCCC/CCHC mutant in this work and in the study
erformed by Demene et al. (1994) and Tanchou et al.
1998). Demene and coworkers were unable to obtain
ull-length genomic RNA from their His-233Cys mutant,
nd they observed extensive degradation of the isolated
iral RNA. RNA levels estimated from both of the studies
ere 10% of wild-type levels. In this study, we could
eadily isolate and identify genomic RNA in our CCCC/
CHC mutant preparation, either by real-time RT-PCR
Table 3) or by Northern blot analysis (data not shown).
Infectivity analysis of virion particles shows that the
utants can be divided into two categories: replication
ompetent and replication defective. Mutants with mod-
fied HIV-1 NC Zn21 fingers in the N-terminal position
CCHH/CCHC, CCHH/CCCC, CCHH/CCHH, CCCC/
CHC, CCCC/CCCC, and CCCC/CCHH) are replication
efective, even when undiluted supernatants were ex-
mined (Fig. 2A). In contrast, the viruses containing wild-
ype NC Zn21 fingers (CCHC) in the N-terminal position
ere replication competent in H9 cells to varying de-
rees. The titers of the CCHC/CCCC and CCHC/CCHH
utants were $101 and $102 TCID/ml, respectively
Figs. 2, B and C). Wild-type virus had a titer of $104
5 cells infected with mutant and wild-type viruses. Hirt fractionated
h supernatants containing mutant and wild-type virus from transfected
P incorporated/ml) of starting inoculum is as follows: (2)-Control, 0;
C/CCHC, 9.7; CCHH/CCHC, 4.8; CCHC/CCCC, 8.3; CCHC/CCHH, 12.2;
s were used in the infection, based on p24CA); IND116N, 13.2; and
e primer pair described by Engelman et al. (1995) for the detection of
supernatants from 293T cells transfected with sheared salmon sperm
ined with ethidium bromide. The positions of the 170-bp 2-LTR circle
hown on the left. Dilutions of the Hirt supernatant DNA before PCR is-clone
ted wit
[3H]TT
.4; CCC
particle
and th
ted with
was sta
s are sCID/ml in this analysis (Fig. 2D). The CCCC/CCCC,
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99HIV-1 NC Zn21 FINGER MUTANTSCCC/CCHH, CCHH/CCCC, CCHH/CCHH, and CCHH/
CHC mutants all packaged reduced levels of genomic
NA (Table 3). The greatest reduction observed was 95%
or the CCCC/CCCC and CCHH/CCCC mutants. The re-
uction in RNA packaging does not fully account for the
04-fold reduction in infectivity. Therefore it is obvious
hat the NC Zn21 fingers are again performing a critical
unction in infection processes, in addition to assembly
rocesses (i.e., RNA packaging).
It is interesting to note that the CCHC/CCHH mutant
aintains the CCHC/CCHH genotype through the 54-day
ourse of the H9 infectivity assay (Fig. 2C). In contrast,
he CCHC/CCCC mutant reverted to a wild-type genotype
CCHC/CCHC) by day 45 (Fig. 2B). The reversion ob-
erved in the CCHC/CCCC mutant is consistent with the
ag in infectivity evident in the 1:10 dilution of the H9
nfectivity assay (Fig. 3B). This lag in infectivity is similar
o the lag observed in a mutant we constructed in which
he first NC Zn21 finger sequence was placed in both the
- and C-terminal NC finger positions (pNC1/1; Gorelick
t al., 1993). The pNC1/1 mutant virus changed after 21
ays in culture such that the kinetics of infection were
imilar to wild-type virus when used to reinfect naı¨ve H9
ells (Gorelick et al., 1993).
The analysis presented in Fig. 2 suggests that the first
inger exerts a greater influence on infectivity than the
econd finger. This is in agreement with our previous
tudies in which HIV-1 mutants were constructed to yield
iruses containing NC proteins with two first Zn21 finger
equences in the N- and C-terminal finger positions
pNC1/1), two second finger sequences (pNC2/2), and
inger switch mutants (pNC2/1; Gorelick et al., 1993). As
pposed to the Zn21 finger mutants presented in this
ork, the Zn21 finger rearrangement mutants presented
n the previous study (Gorelick et al., 1993) retained
etroviral Zn21 finger motifs (CCHC) in each position of
he NC protein, with only the amino acids in the loops
etween the Zn21 ligand binding residues being
hanged. In both of these studies, only the mutants that
etained the authentic CCHC sequence in the N-terminal
osition were infectious. This emphasizes that the NC
n21 finger in the N-terminal position is more sensitive to
lteration with respect to infectivity than the finger in the
-terminal position.
Most of the HIV-1 mutants that were replication defec-
ive in bulk culture (H9 or AA2-clone 5 cell assays) were
lso unable to induce significant b-galactosidase signals
hen HCLZ cells were incubated with mutant virus con-
aining supernatants (Table 2). Previous reports indicate
hat unintegrated forms of vDNA could still be tran-
cribed to produce viral encoded proteins (Stevenson et
l., 1990) or score positively in the MAGI assay (En-
elman et al., 1995; Kimpton and Emerman, 1992), an
ssay that uses the same reporter gene and CD4 recep-
or in its cells as the HCLZ cells. Thus it could be
oncluded that these mutants have a defect in RT pro- qesses. This conclusion is also supported by the inability
o detect the 170-bp PCR product that is indicative of the
resence of full-length, 2-LTR circularized vDNA. The
CCC/CCCC mutant packages the least amount of viral
NA (Table 3) and also had the lowest level of inoculum
sed for incubation with the AA2-clone 5 cells (see Fig.
legend) before isolation of the Hirt supernatant DNA. If
ild-type levels of full-length vDNA were generated, on a
er-genome basis in these mutants, one would expect,
t most, a 100-fold reduction in the PCR signal, which
hould be detectable (based on the wild-type sample;
ig. 3). Thus there appears to be a reduction in the level
f full-length vDNA produced by these mutants, which
ould account for the 104-fold decrease in infectivity in
he replication-defective mutants. A similar defect was
bserved in the Mo-MuLV CCCC and CCHH mutants
ecause full-length vDNA was not detected by Southern
nalysis of Hirt supernatant DNA from cells infected with
he mutant viruses (Gorelick et al., 1996).
The CCCC/CCHC mutant appears to be different from
he rest of the replication-defective mutants. This mutant
as ;5% wild-type levels of infectivity when measured in
CLZ cells (Table 2). This suggests that RT processes
re operable, at least with respect to the generation of
pliced message that can be translated to produce Tat.
owever, this mutant is replication defective in H9 cells
Fig. 2A). This result suggests a possible defect in inte-
ration processes because the CCCC/CCHC mutant has
recisely the same phenotype as the IND116N mutant
escribed by Engelman et al. (1995). Both the CCCC/
CHC and the IND116N mutants score positively in the
CLZ (Table 2) or MAGI (data not shown) assays, but
either are replication competent as determined by cul-
ivation in H9 cells. In addition, both the CCCC/CCHC
nd IND116N mutants produce vDNA after infection of
ermissive cells that can be detected by PCR (Fig. 3). It
s interesting to note that the IND116N mutant produces
DNA that can be detected at a 1:1000 dilution and the
ild-type virus is detected at a 1:100 dilution (Fig. 3). The
ame amounts of wild-type and IND116N viruses were
sed to infect the AA2-clone 5 cells (based on RT anal-
sis). This would suggest that ;90% of the vDNA in the
ild-type infection was integrated.
A recent report (Tanchou et al., 1998) suggests that RT
ay be affected because 1- or 2-LTR circle forms of
DNA were not detected in SupT1 cells infected with the
CCC/CCHC (His-233Cys) mutant. We were in fact able
o detect significant 2-LTR circular forms of vDNA from
A2-clone 5 cells infected with the CCCC/CCHC mutant
Fig. 3). The discrepancy with respect to the PCR results
ay be due to differences in the cells that were used for
solation of the Hirt supernatant vDNA after infection
AA2-clone 5 versus HeLa P4 cells) or also may be due
o differences in the level of sensitivity between the two
CR analyses. Consequently, further studies will be re-
uired to determine whether this particular mutant has
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100 GORELICK ET AL.reverse transcription defect, an integration defect, or a
ombination of both defects.
It must also be emphasized that the retroviral NC
rotein performs several roles in the virus replication
ycle in addition to those discussed thus far. Some of
hese essential roles depend on the presence of func-
ional retroviral (CCHC) NC Zn21 fingers, and some de-
end on the presence of NC fingers that are competent
n binding a Zn21 ion, whereas others are to a large
xtent independent of the Zn21 fingers. These additional
oles include single-stranded nucleotide melting and an-
ealing reactions (DeRocquigny et al., 1992; Prats et al.,
991), RNA dimer stabilization (Feng et al., 1996; Fu et al.,
994; Fu and Rein, 1993), primer tRNA annealing (Li et al.,
996; Prats et al., 1988), strand transfer reactions that
ccur during reverse transcription (Allain et al., 1994;
uo et al., 1997; Rodriguez-Rodriguez et al., 1995; Tsuchi-
ashi and Brown, 1994; You and McHenry, 1994), and
lleviation of pausing during reverse transcription due to
econdary structures in single-stranded nucleotide re-
ions (Wu et al., 1996). These additional roles are all
anifestations of the nucleic acid chaperone activity of
he NC protein or the NC domain of the Gag polyprotein
Rein, et al., 1998).
Efficient packaging of genomic RNA appears to re-
uire an intact NC Zn21 finger. However, the retroviral
CHC finger can be substituted with either a CCCC or a
CHC for this function, as shown with some of the
utants in this study, the mutagenesis experiments with
o-MuLV (Gorelick et al., 1996), and in vitro binding
tudies of mutant NC proteins to nucleic acid packaging
egions performed by Dannull et al. (1994). These studies
oupled with the previous Mo-MuLV mutant analyses
Gorelick et al., 1996) suggest that the evolutionary pres-
ure to maintain specifically the CCHC NC Zn21 finger
ot only is due to its function in genomic RNA packaging
ut also appears mainly to be due to a requirement in a
tep before generation of the provirus. Mutants de-
cribed in this study, combined with Mo-MuLV NC Zn21
inger mutants (Gorelick et al., 1996), should provide
ppropriate tools to allow identification of the essential
ole of the NC CCHC finger in virus replication.
MATERIALS AND METHODS
ell lines
The H9 (Popovic et al., 1984), AA2-clone 5 (Chaffee et
l., 1988), 293T (293 cell line containing the simian virus
0 large T antigen; Gorelick et al., 1996), and the HCLZ
CD4 producing HeLa cells containing an HIV-1 LTR/b-
alactosidase construct; Gorelick et al., 1993) cell lines
ere described previously. The H9, AA2-clone 5, and
CLZ cell lines were cultured in the presence of hexa-
imethrine bromide (Polybrene; 2 mg/ml) to increase viralnfectivity by reducing electrostatic repulsion between Ahe virus and target cells. All lines were maintained in 7%
O2 at 37°C unless otherwise noted.
lasmids
The plasmids pNL4–3 (an infectious clone of wild-type
IV-1 NY5/LAV; Adachi et al., 1986) and pDR0 (Gorelick
t al., 1993) have been described. Plasmids containing
clI sites used for cloning were grown in the dam/dcm-
eficient Escherichia coli strain GM2163 (New England
iolabs, Beverly, MA). The plasmid, based on the pNL4–3
lone of HIV-1 that produces the IND116N mutant virus
Engelman et al., 1995), was a gift obtained from Alan
ngelman and Joseph Sodroski (Dana Farber Cancer
nstitute, Boston, MA).
utagenesis
Primers were obtained from either Marilyn Powers of
he DNA Support Laboratory to ABL-Basic Research Pro-
ram, SAIC-Frederick, National Cancer Institute-Freder-
ck Cancer Research and Development Center (NCI-
CRDC); Operon Technologies, Inc. (Alameda, CA); or
ife Technologies (Gaithersburg, MD) The following oli-
onucleotides were used for mutagenesis of the pNL4–3
lasmid (Adachi et al., 1986), PCR, and hybridizations.
he nucleotide (nt) positions correspond to positions in
he pNL4–3 sequence (GenBank accession no. M19921).
egions in parentheses indicate restriction sites [HindIII
59-AAGCTT-39) or ApaI (59-GGGCCC-39)]. Underlined
ortions of sequences indicate the location of mutations.
talicized regions do not correspond to viral sequences
ut indicate bases that were used as a leader for ApaI
igestion of PCR products (see below): OSL 2694, 59-
AG AGC CGA GC(A AGC TT)C ACA-39, has sense
trand sequence and 59 end corresponds to nt position
701; 4658-089, His-233Cys mutagenic oligonucleotide,
9-TAT (GGG CCC) TGC AAT TTT TGG CTA TGC ACC CTT
-39, has antisense strand sequence and 59 end corre-
ponds to nt position 2011; 4658-096, Cys-283His mu-
agenic oligonucleotide, 59-ATA (GGG CCC) TGT GAT TTT
GG CTA TG-39, has antisense strand sequence and 59
nd corresponds to nt position 2011; OSL 2129, 59-ATG
TA CAG AAA GGC AAT TTT-39, has sense strand se-
uence and 59 end corresponds to nt position 1918;
658-073, His-443Cys mutagenic oligonucleotide, 59-
GA AGG ATG CCA AAT GAA AGA TTG-39, has sense
trand sequence and 59 end corresponds to nt position
043; 4658-074, Cys-493His mutagenic oligonucleotide,
9-GAA AGA TCA TAC TGA GAG ACA GGC-39, has sense
trand sequence and 59 end corresponds to nt position
058; 4658-091, 59-GCT TTA TGT CCG CAG ATT TC-39,
as antisense strand sequence and 59 end corresponds
o nt position 2464; 4658-092, 59-AAT TAG CCT GTC TCT
AG TA-39, has antisense strand sequence and 59 end
orresponds to nt position 2086; and 4658-093, 59-CTC
GT ACA ATC TTT CAT TTG G-39, has antisense strand
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101HIV-1 NC Zn21 FINGER MUTANTSequence and 59 end corresponds to nt position 2073.
he His-233Cys and Cys-283His mutations create
CCC and CCHH types of fingers in the N-terminal po-
ition, respectively, in HIV-1 NC. The His-443Cys and
ys-493His changes create CCCC and CCHH types of
ingers in the C-terminal NC finger position, respectively.
CCC, CCHH, and CCHC refer to ligand binding residues
n the NC Zn21 fingers.
Mutations were introduced by PCR using a Perkin–
lmer PE9600 thermocycler and Perkin–Elmer AmpliTaq
ore reagents (Foster City, CA) according to the manu-
acturer’s instructions. All amplifications for mutagenesis
ere performed using 25 cycles of melting at 94°C (45 s),
nnealing at 50°C (35 s), and extending at 72°C (40 s).
ne final extension cycle was performed at 72°C for 8
in. The His-233Cys mutation in the gene coding for
he NC protein of HIV-1 (pNL4–3) was introduced using
rimers OSL 2694 (the 59 oligonucleotide containing a
indIII restriction site) and 4658-089 (the 39 oligonucle-
tide containing the base changes to introduce the His-
33Cys mutation and an ApaI restriction site). The re-
ulting PCR product was 294 bp after digestion with
indIII and ApaI. The Cys-283His mutation was intro-
uced in the same fashion using primers OSL 2694 and
658-096. Cloning into the full-length plasmid is de-
cribed below.
The His-443Cys and Cys-493His mutations were
ade in a two-step process similar to the “overlap ex-
ension” method described previously (Horton et al.,
990). For each mutant, the first step involved amplifying
9 and 39 PCR fragments using the following primers. For
he His 443Cys mutation, the 59 portion was generated
sing primers OSL 2129 and 4658-093. The 39 portion
as generated using primer 4658-073. For the Cys-
93His mutation, the 59 portion used primers OSL 2129
nd 4658-092, and the 39 portion was generated using
rimers 4658-074 and 4658-091. The primers and nucle-
tides were removed from the PCR products by agarose
el electrophoresis [a combination of 3% (w/v) NuSieve
TG and 1% (w/v) SeaKem LE agaroses (FMC BioProd-
cts, Rockland, ME) using 89 mM Tris base, 89 mM boric
cid, and 20 mM EDTA, pH 8.0 (TBE) buffer], electro-
luted from the agarose, phenol/chloroform/isoamyl al-
ohol extracted twice, and ethanol precipitated. The 59
nd 39 fragments for each mutant were combined and
mplified as described above using primers 2129 (the 59
ligonucleotide) and 4658-091 (39 oligonucleotide).
The final PCR products were isolated by agarose gel
lectrophoresis and purified as described above. Frag-
ents were then digested with the respective restriction
nzymes yielding 298-bp HindIII–ApaI fragments for the
is-233Cys or Cys-283His mutants and 419-bp ApaI–
clI fragments for the His-443Cys or Cys-493His mu-
ants, respectively. These fragments were then cloned
nto the homologous sites of pDR0 (Gorelick et al., 1993)
n the various combinations listed in Table 1. Prospective Ilones were identified by colony hybridization and li-
ated into full-length provirus-containing plasmids as
escribed previously (Gorelick et al., 1993). All of the
utations were verified using the Sequenase version 2.0
NA sequencing kit (Amersham Pharmacia Biotech, Inc.,
iscataway, NJ).
To create the HIV-1 RTD185K/D186L mutant, changes
ere introduced into the pDR0 plasmid using the Strat-
gene Quick Change site-directed mutagenesis kit (La
olla, CA) with the following oligonucleotides: E0141B09,
9-CAT AGT CAT CTA TCA ATA CAT GAA GCTTTT GTA
GT AGG ATC TGA C-39 (59 end corresponds to nt posi-
ion 3080, GenBank accession no. M19921) and
0141B10, 59-GTC AGA TCC TAC ATA CAA AAG CTTCAT
TA TTG ATA GAT GAC TAT G-39 (59 end corresponds to
t position 3125). The bases that were changed to intro-
uce the mutation are underlined. The oligonucleotides
sed to introduce the RTD185K/D186L mutations were ob-
ained from Life Technologies. The pDR0 plasmid with
he mutations was digested with the restriction endo-
ucleases SpeI and SalI, and the 4278-bp SpeI–SalI
ragment was cloned into the homologous sites of the
NL4–3 plasmid. The mutations for RTD185K/D186L were
erified by sequence analysis.
ransfections
293T cells were transfected by the calcium phosphate
recipitation method (Graham and Van der eb, 1973)
sing the Calcium Phosphate Mammalian Cell Transfec-
ion Kit from 5 Prime-3 Prime(Boulder, CO) as described
Gorelick et al., 1996). All supernatants were clarified by
entrifugation for 10 min at 760g. HCLZ cells were trans-
ected and samples processed as described previously
Gorelick et al., 1993).
T assays
RT assays were performed on clarified supernatants
s described previously (Gorelick et al., 1990) with the
ollowing changes. Instead of concentrating virus ob-
ained from transfections by precipitation in the presence
f polyethylene glycol, virus was pelleted from 4.2 ml of
larified supernatants by centrifugation at 20,500g in a
odel SW60Ti rotor (Beckman Instruments Inc., Fuller-
on, CA) for 1 h at 4°C. The viral pellet was resuspended
n 100 ml of 50 mM Tris buffer, pH 7.5, with 100 mM NaCl
nd 1 mM EDTA. Then, 5 ml of the resuspended viral
ellet was analyzed.
iral protein analysis
Immunoblot analysis was performed as described pre-
iously (Gorelick et al., 1990). The blot was incubated first
ith monoclonal antisera to gp120SU, next with goat p7NC
ntisera, and finally with goat p24CA antisera. Viral pro-
eins were detected using the Amersham Life Science
nc. ECL Western blotting analysis system (Arlington
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102 GORELICK ET AL.eights, IL) in combination with goat-anti-mouse IgG-
orseradish peroxidase conjugate (for a-gp120SU) or rab-
it-anti-goat IgG-horseradish peroxidase conjugate (for
-p24CA and a-p7NC) (Bio-Rad, Hercules, CA). The same
embrane was used with all three antibodies. Antibod-
es were removed from the Immobilon-P membrane (Mil-
ipore Corp., Bedford, MA) after detection of each viral
rotein according to Amersham Life Science Inc. proto-
ols.
p24CA antigen ELISA analysis was performed accord-
ng to the written protocols and reagent kits provided by
he Biological Products Laboratory, AIDS Vaccine Pro-
ram, NCI-FCRDC.
RNA analysis
RNA was isolated as described previously (Fu et al.,
994). Briefly, virus pelleted at 120,000g in a Beckman
W28.1 rotor from 30 ml of culture fluid was disrupted in
00 ml of sterile buffer containing 50 mM Tris buffer, pH
.4, 100 mM NaCl, 10 mM EDTA, 1.0% (w/v) SDS, 50 mg/ml
f yeast tRNA (Life Technologies) and 100 mg/ml Protein-
se K (Life Technologies). Samples were incubated at
7°C for 2–4 h. Samples were extracted twice with an
qual volume of phenol/chloroform/isoamyl alcohol (25:
4:1, v/v) and then ethanol precipitated. Samples were
entrifuged to collect the precipitated RNA and the pel-
ets were dissolved in 0.1 ml of buffer containing 40 mM
ris–HCl, pH 7.9, 10 mM NaCl, 6 mM MgCl2, 10 mM
aCl2, and 10 U of RQ1 RNase-free DNase (Promega,
adison, WI) to remove contaminating DNA. Samples
ere incubated at 37°C for 1 h, and reactions were
erminated with the addition of 0.2 ml of 4.0 M guanidine
hiocyanate, 0.3 M sodium acetate, pH 6.0, and 0.12 M
-mercaptoethanol. Samples were ethanol precipitated
gain, rinsed with 70% ethanol, dried, and resuspended
n 50–100 ml of sterile RNase-free water containing 400
/ml of RNASEOUT RNase inhibitor (Life Technologies).
Real-time RT-PCR for determining HIV-1 viral RNA lev-
ls were performed essentially as described for the
uantification of SIV gag RNA (Suryanarayana et al.,
998). Briefly, random primed cDNA was amplified using
he following reagents, essentially as described by Ros-
io et al. (1998). The forward primer (HUS-462b) has the
equence 59-GIC ATC AIG CAG CCA TGC AAA T-39 and
he reverse primer (HUS-R04) has the sequence 59-CAT
CT ATT TGT TCI TGA AGG GTA CTA G-39, where “I”
ndicates inosine residues. The 59 ends of these oligo-
ucleotides correspond to nucleotide positions 1367 and
535 bp, respectively, in the pNL4-3 nucleotide sequence
GenBank accession no. M19921). The resulting PCR
roduct is 169 bp and lies within the HIV-1 gag gene. The
robe (P-HUS-102c), which was labeled with the reporter
luorophor 6-carboxy-fluorescein on the 59 end and the
uencher dye 6-carboxy-tetramethyl-rhodamine conju-
ated through a linker arm nucleotide on the 39 end eLivak et al., 1995), has the sequence 59-TCA ATG AGG
AG CTG CAG AAT GGG AT-39 (59 end corresponds to nt
osition 1403 of the pNL4-3 nucleotide sequence). The
pplied Biosystems (Foster City, CA) Prism 7700 thermo-
ycler was used for real-time quantification of cDNA as
escribed previously (Gibson et al., 1996; Heid et al.,
991; Suryanarayana et al., 1998) using AmpliTaq Gold
Perkin–Elmer) and the following temperature profile:
5°C for 10 min and then 45 cycles of 95°C for 15 s, 55°C
or 30 s, and 60°C for 30 s.
irus infectivity assays
Clarified samples from transfected 293T cells were
nalyzed by limiting dilution for infection on H9 and
CLZ cells as described previously (Gorelick et al., 1993,
990). Infectivity assays using AA2-clone 5 cells were
erformed under the same conditions as the H9 infec-
ivity assays except the cells were cultured in RPMI 1640
edia containing 10% (v/v) FBS.
nalysis of vDNA from infected cells
Detection, isolation, and sequencing of proviral NC
rotein gene sequences from H9 cells cultured in the
nfectivity assays were performed as follows; 2 ml of
ells and culture fluids were frozen at 270°C from each
ample during routine harvesting of supernatants from
9 infectivity assays. Samples of interest were later
hawed, cells were pelleted, and the cells were resus-
ended in 1 ml of 4 M guanidine thiocyanate, 25 mM
odium acetate, and 0.84% (v/v) b-mercaptoethanol, pH
.0. Total cell DNA (and RNA) was isolated as described
reviously (Bess et al., 1997). The resulting nucleic acid
ellet was resuspended in 100 ml of TE (10 mM Tris–HCl,
mM EDTA), pH 8.0. Then, 2 ml of the resuspended total
ell DNA was subjected to PCR in a Perkin–Elmer 9600
hermocycler using primers from Life Technologies cho-
en to amplify nucleotide sequences coding for the NC
rotein (NL43-NC-sense: 59-GAT ACA GAA AGG CAA
TT TAG GAA C-39; NL43-NC-antisense: 59-CTT GTG
GA AGG CCA GAT CTT C-39). The position of the 59
nds of each primer correspond to nt 1920 and 2115 bp
GenBank accession no. M19921) for NL43-NC-sense
nd NL43-NC-antisense, respectively.
The 100-ml reaction volumes were used in the pres-
nce of 4 mM MgCl2, 8 mM concentration of each of the
rimers, and AmpliTaq Gold according to the protocol
rovided by Perkin–Elmer, Roche Molecular Systems,
nc. (Branchburg, NJ). The PCR mixtures were incubated
s follows: 1 cycle of 94°C for 9 min; 30 cycles of 94°C
or 15 s, 60°C for 30 s, and 67°C for 45 s; and one cycle
t 67°C for 8 min. Then, 15 ml of the samples was
nalyzed by agarose gel electrophoresis, with ethidium
romide-stained band intensities compared with those of
mg of fX174-HaeIII digested DNA. The remainder ofach sample was treated to remove primers and nucle-
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103HIV-1 NC Zn21 FINGER MUTANTStides and sequenced using an ABI Prism 373 auto-
ated sequencer and the ABI Prism Dye Terminator
ycle Sequencing Ready Reaction Kit with DNA Ampli-
aq DNA Polymerase (Applied Biosystems) according to
he manufacturer’s instructions. The NL43-NC-sense and
antisense primers were used for the sequencing reac-
ion.
Analysis of 2-LTR circular forms of vDNA from mutant
nd wild-type viruses used to infect AA2-clone 5 cells
as performed using the primers and procedures de-
cribed by Engelman et al. (1995). AA2-clone 5 cells (2 3
07) were incubated with 60 ml of clarified culture fluid
ontaining transiently expressed mutant or wild-type vi-
us. At 24 h after infection, vDNA was obtained from all
ultures according to the method described by Hirt
1967). The Hirt fractionated DNA supernatant was pre-
ipitated in the presence of 70% ethanol and 0.3 M
odium acetate, pH 5.2, overnight at 20°C. The precipi-
ate was collected by centrifugation, washed with cold
0% ethanol, dried, and resuspended in 50 ml of TE, pH
.0. Then, 2 ml of each sample was subjected to PCR in
0-ml reaction volumes under the conditions described
y Engelman et al. (1995) except that AmpliTaq Gold
Perkin–Elmer, Roche Molecular Systems, Inc.) was used
nstead of AmpliTaq and a 9-min incubation at 94°C was
sed before the incubation protocol described by En-
elman et al. (1995). Then, 20 ml of the PCR products
rom the vDNA analyses was fractionated on a 2% (w/v)
etaPhor agarose (FMC BioProducts) gel in TBE buffer.
CR products were visualized by ethidium bromide
taining.
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